如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)
中国中重度斑块状银屑病患者中依奇珠单抗的药代动力学特征、安全性和有效性:一项单组和多组剂量1期研究结果
返回Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study
作者:Min Zheng, Xiang Chen, Feng Wang, Jisu Chen, Kimberley Jackson, Fan Yang, Christopher Payne, HongYing Li, YiHui Wang, ZiPei Xiao & Jie Zheng 期刊:Advances in Therapy发表日期:6/25/2023卷/期/页码:Online First
